Konferenzen  >  Biowissenschaften  >  Biotechnologie

Cambridge Healthtech Institute (CHI)

CHI announces final details for the 30th International Biodetection Technologies virtual conference on June 7-8, 2023. This internationally recognized meeting is for experts in detection & identification of biological threats. This 2-part event will address the key topics in detection and present the latest R&D and technological innovation in ready-to-market systems. In addition, this meeting focuses on the latest strategies to overcoming the hurdles to the identification of global biological threats and translational gaps in bringing technologies from lab to field. This virtual event will livestream on Eastern Daylight Time (EDT).

Tel.: [+1 781-972-5400];     Email: jprudhomme@healthtech.com

biodetection technologies, biothreats, pathogens, point-of-care diagnostics, biosurveillance, diagnostics, infectious diseases, microbiology, sample preparation technologies

Society for In Vitro Biology

The Society for In Vitro Biology (SIVB) is heading to Norfolk, Virginia for the 2023 SIVB Annual Meeting for the first time ever and you can be part of it! Founded nearly 80 years ago as the Tissue Culture Association, the SIVB is fostering the exchange of knowledge of in vitro biology of cells, tissues, and organs from both the plant and animal kingdoms, including humans. The SIVB furthers biotechnology research to understand biology at the cellular and developmental level, and promotes, expands and supports the scientific knowledge base for the benefit of society as a whole. The scientific program will provide both state-of-the-art scientific research and core fundamentals presented by speakers you won’t want to miss. This year’s plenary topics include: Microbiomes, Product Development, Spatial Biology, Biotechnology for Sustainability, and Diversity in Science.

Tel.: [910-755-5431];     Email: sivb@sivb.org

Biotechnology, gene editing, CRISPR, cell culture, tissue culture, organoid

Biologie,    Genetik und Erbkrankheiten

IMAPAC

Biologics Manufacturing Europe 2023 is the European region’s premier conference for the manufacturing community. This event connects the leaders of Biologics and Biosimilars Manufacturers to debate best practices in upstream and downstream bioprocessing.

Frankfurt, Germany will host this bioprocessing-focused, knowledge-sharing conference to provide regional biopharmaceutical industry stakeholders a carefully tailored networking platform for leveraging opportunities for strategic collaboration, and exposure to the latest manufacturing technologies and know-how. We have an agenda built around success stories from Europe's biopharmas as well as the technical expertise from International Biopharmas and BIG Pharmas, presentations on the latest manufacturing technologies such as single-use and end-to-end continuous processing for biologics, today’s challenges and opportunities in biomanufacturing, advances in upstream process development, cost-optimization strategies in downstream processing, analytical characterization strategies, facility design, and scale-up strategy, fill & finish innovation to streamline the operations amongst other crucial themes.

Marketing Executive;     Email: roxanne.chetty@imapac.com

Biologics, Biologics Manufacturing, Contract Manufacturing, Biotechnology, BME2023

Cambridge Healthtech Institute

Newer and more complex molecules often complicate existing downstream processes. New, innovative technologies are necessary to ensure safe, efficient, and effective capture and purification of emerging modalities. In this interactive virtual event, our experts share their personal experiences and insight to help anticipate challenges and chose appropriate technologies to support your downstream strategies. Topics include advances in downstream purification processes new therapeutic modalities, vector increased, downstream processing challenges, and more.

Cambridge healthtech Institute;     Tel.: [7819725400];     Email: chi@healthtech.com

Biotechnology, Pharmacology, Pharmaceuticals

Faculty of Biology, Adam Mickiewicz University, Poznan

We are pleased to invite you to participate in the fourteenth edition of the Poznan Summer School of Bioinformatics organized by the Faculty of Biology of Adam Mickiewicz University, Poznan, Poland. The title of this year's edition is "Analysis of single-cell data". The course is suitable for beginners as well as for those with basic knowledge in the field of bioinformatics and will be held in English. The course will be largely hands-on, allowing you to familiarize yourself with the topics discussed and to practice the problems presented.

PSSB Organizing Committee;     Email: genomics@amu.edu.pl

Introduction to R, Introduction to Bioconductor, scRNA-seq Data Analysis, Single Cell Metabolomics, Correlation-based Network Analysis of Metabolites

Genomforschung und Bioinformatik,    Molekularbiologie

Cambridge Healthtech Institute (CHI)

CHI's Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, decentralized testing, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care. Now in its fifteenth year, the Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important topics for the industry.

Tel.: [+1 781-972-5400];     Email: reg@healthtech.com

diagnostics, liqid biopsy, cancer, cancer detection, diagnostic testing, diagnostic reimbursement, infectious diseases, poin-of-care, point-of-care diagnostics, POC testing

EBD Group

BioPharm America™ is a unique partnering conference where the new wave of life science innovators partner to fuel the future of drug development. For the first time, this event will be held in Raleigh, North Carolina, September 13–14, 2023, a booming hub of research, innovation, manufacturing, and partnerships.

Customer Service;     Email: ebdcustomerservice@ebdgroup.com

biopharma, venture capital, business development, pharmaceuticals, partnering

Oxford Global Conferences

Join oligo leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the oligonucleotides chemistry & therapeutics development.

Tel.: [+44 1865 248455];     Email: h.liddiard@oxfordglobal.co.uk

Oligonucleotides chemistry, biotechnology, oncology, Genetic disorders, Rare diseases, Infectious diseases, Cardiovascular diseases, Kidney diseases

Molekularbiologie,    Onkologie

Oxford Global Conferences

Learn from key opinion leaders working to deliver RNA therapies for several therapeutic areas including infectious disease and cardiovascular disease. Across two in-depth sessions the latest improvements pushing the industry forward will be addressed: from RNA formulation strategies, design and development through to antisense and oligo-mediated RNA delivery and improvements in extrahepatic delivery approaches.

Tel.: [+44 1865 248455];     Email: h.liddiard@oxfordglobal.co.uk

RNA, Nanoparticles, Immunology, mMRA, Oligonucleotides

DECHEMA

The next ECCE/ECAB will take place as a face-to-face event from 17-21 September 2023 at the CityCube in Berlin/Germany. Make a note of this date in your calendar and look forward with us to interesting presentations, interactive exchange with colleagues, the diverse range of exhibitors and sponsors as well as a supporting programme that offers plenty of time for networking.

A - Green Deal – a common task for chemical and biochemical engineers; B - Chemical and Biochemical Engineering in Medicine; C - Acting Together - Biochemical and Chemical Engineering Integration; D - Matter in Motion; E - Faster and More Selective; F - Solid Matter; G - Tools and Toolkits for Chemical and biochemical reactors; H - Digital transformation; I - Early career programme

European Molecular Biology Laboratory | EMBL

This course will provide training in genome editing and cell engineering in mammalian cells and mouse embryos using the highly efficient CRISPR/Cas9 system. Participants will learn design of CRISPR targets using bioinformatics tools, generation of gene knock-outs/knock-ins, and target validation using the most current technologies.

Molekularbiologie,    Genomforschung und Bioinformatik

Uventia Global

Highly potent active pharmaceutical ingredients, or HPAPIs, are potent compounds that could effectively treat serious and life-threatening diseases such as cancer. Because of their high potency, these substances eventually put the workers in the production facility at risk. While exceptional product quality is required, additional measures must be taken to ensure operator safety. At our online meeting, leading figures from the industry, occupational toxicologists and containment specialists will review the most recent developments affecting the handling of HPAPIs. The discussion will center on the safe and effective processing of potent APIs, process development and scale-up, occupational health hazards, toxicological assessment, improvements in isolators and facilities to minimize exposure risk, containment and cleaning validation practices, and risk management for cross-contamination.

Email: yuliia.terletska@uventia.com

HPAPI, API, Compounds Manufacturing, Occupational Toxicology, Industrial Hygiene, Process Engineering, Process Development, Containment, Cross Contamination, Cleaning Validation, Cleanroom, Risk Management, Quality Assurance, Quality Control, Analytical Development, Analytical Methods, Outsourcing

Biochemie und Medizinische Chemie, Toxikologie,    Pharmakologie und Arzneimittelentwicklung

Oxford Global Conferences

Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine

Oxford Global Conferences;     Tel.: [+44 1865 248455];     Email: b.westmore@oxfordglobal.co.uk

Biomarkers, Personalised Medicine, Oncology, Infectious Disorders, Imaging Technologies, Digital Pathology, Flow Cytometry, Immunoassays, Genomic Markers, Precision Medicine

The 29th annual BIO-Europe will take place November 6–8, 2023 in Munich, Germany, and it will convene over 5,000 life science professionals representing more than 2,220 companies from over 60 countries. Attendees will take part in 27,000 one-to-one meetings over the course of the event. Over the last 29 years, BIO-Europe, year after year, has grown not just in size but most importantly in becoming Europe’s flagship partnering event. Its international reach makes it a one of a kind offering and the gateway to the global life science community. Attendees from all parts of the biotechnology value chain gather to efficiently identify, engage and form strategic relationships that drive their businesses successfully forward.

Customer Service;     Email: EBDcustomerservice@ebdgroup.com

partnering, business development, biotech, start-up, pharmaceutical, medical device, diagnostic, licensing, finance, life science

The International Biotechnology Symposium Congress will be jointly organized with ECB, the Congress of European Federation of Biotechnology and with NBC, the annual Netherlands Biotechnology Conference, in Maastricht.

On behalf of the Dutch Biotechnology Association (NBV), we warmly welcome you to participate in this major world Biotechnology Congress in the beautiful city of Maastricht, the Netherlands. This will be a joint Congress, IBS2024 and ECB2024. The annual Netherlands Biotechnology Conference, NBC-24, as well as other highlight and satellite events from partners will complete the program. Since 1960, IBS2024 has been the major event organised by the biotechnology sub-division of IUPAC, the International Union of Pure and Applied Chemistry. ECB2024 is the 19th Congress organised by the European Federation of Biotechnology.